The Power of RNA Amplified
Impact measured in billions.
YOUR CELLs’ vERY OWN COPY MACHINERY
Our platform leverages next-generation self-replicating RNA (srRNA) vectors. Once inside cells, the genetic code of our srRNA drives repeated production of natural RNA, resulting in outsized protein expression and durable therapeutic effect.
OUR SCIENCe
ENABLING BROAd APPLICATIONs FOR RNA TREATMENTs
Replicate is advancing a robust pipeline of srRNA treatments spanning several therapeutic areas, including infectious disease, oncology, and autoimmune disorders. Improved performance over linear mRNA lets us help even more patients.
PIPELINe
News & Publications
01.08.26
Press Releases
Replicate Bioscience Awarded Grants to Develop New srRNA Vaccines for HIV and Malaria
12.16.25
Press Releases
Replicate Bioscience Appoints Kathy Fernando, Ph.D., as Chief Business Officer
12.04.25
Press Releases
Replicate Bioscience and Instituto Butantan Enter Collaborative Agreement to Develop and Commercialize Replicate’s Self-Replicating RNA (srRNA) Rabies Vaccine in Latin America